Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer.
Alderman B, Hui D, Mukhopadhyay S, Bouleuc C, Case AA, Amano K, Crawford GB, de Feo G, Sbrana A, Tanco K, To J, Garsed J, Davis M. Alderman B, et al. Among authors: sbrana a. Support Care Cancer. 2022 Dec 16;31(1):39. doi: 10.1007/s00520-022-07480-x. Support Care Cancer. 2022. PMID: 36525085 Review.
Management of Thyrotoxicosis Induced by PD1 or PD-L1 Blockade.
Brancatella A, Lupi I, Montanelli L, Ricci D, Viola N, Sgrò D, Antonangeli L, Sardella C, Brogioni S, Piaggi P, Molinaro E, Bianchi F, Aragona M, Antonuzzo A, Sbrana A, Lucchesi M, Chella A, Falcone A, Del Prato S, Elisei R, Marcocci C, Caturegli P, Santini F, Latrofa F. Brancatella A, et al. Among authors: sbrana a. J Endocr Soc. 2021 May 15;5(9):bvab093. doi: 10.1210/jendso/bvab093. eCollection 2021 Sep 1. J Endocr Soc. 2021. PMID: 34337277 Free PMC article.
Pharmacogenetics of androgen signaling in prostate cancer: Focus on castration resistance and predictive biomarkers of response to treatment.
Del Re M, Crucitta S, Restante G, Rofi E, Arrigoni E, Biasco E, Sbrana A, Coppi E, Galli L, Bracarda S, Santini D, Danesi R. Del Re M, et al. Among authors: sbrana a. Crit Rev Oncol Hematol. 2018 May;125:51-59. doi: 10.1016/j.critrevonc.2018.03.002. Epub 2018 Mar 6. Crit Rev Oncol Hematol. 2018. PMID: 29650277 Review.
[18F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer.
Pasqualetti F, Panichi M, Sollini M, Sainato A, Galli L, Morganti R, Chiacchio S, Marciano A, Zanca R, Mannelli L, Coraggio G, Sbrana A, Cocuzza P, Montrone S, Baldaccini D, Gonnelli A, Molinari A, Cantarella M, Mazzotti V, Ricci S, Paiar F, Erba PA. Pasqualetti F, et al. Among authors: sbrana a. Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):185-191. doi: 10.1007/s00259-019-04482-6. Epub 2019 Oct 16. Eur J Nucl Med Mol Imaging. 2020. PMID: 31620808 Free PMC article.
CYP17A1 polymorphism c.-362T>C predicts clinical outcome in metastatic castration-resistance prostate cancer patients treated with abiraterone.
Crucitta S, Del Re M, Paolieri F, Bloise F, Sbrana A, Sammarco E, Mercinelli C, Cucchiara F, Fontanelli L, Galli L, Danesi R. Crucitta S, et al. Among authors: sbrana a. Cancer Chemother Pharmacol. 2020 Oct;86(4):527-533. doi: 10.1007/s00280-020-04133-w. Epub 2020 Sep 18. Cancer Chemother Pharmacol. 2020. PMID: 32945940
Prognostic impact of conservative surgery for pancreatic IPMNs.
Palmeri M, Di Franco G, Bianchini M, Guadagni S, Gianardi D, Furbetta N, Caprili G, Fatucchi LM, Sbrana A, Funel N, Pollina LE, Di Candio G, Morelli L. Palmeri M, et al. Among authors: sbrana a. Surg Oncol. 2021 Sep;38:101582. doi: 10.1016/j.suronc.2021.101582. Epub 2021 Apr 16. Surg Oncol. 2021. PMID: 33892432
89 results